Presart HZ 80 mg+12.5 mg (Tablet)
Unit Price: ৳ 15.00 (3 x 10: ৳ 450.00)
Strip Price: ৳ 150.00
Medicine Details
Category | Details |
---|---|
Generic | Telmisartan hydrochlorothiazide |
Company | General pharmaceuticals ltd |
Also available as |
Indications
- Treatment of hypertension
- Lowering blood pressure
- Prevention of fatal and nonfatal cardiovascular events
- Stroke risk reduction
- Myocardial infarction risk reduction
Pharmacology
- Telmisartan blocks vasoconstrictor effects of angiotensin II
- Blocks aldosterone-secreting effects
- Does not inhibit ACE (kininase II)
- Does not bind to other hormone receptors
- Hydrochlorothiazide is a thiazide diuretic
- Increases excretion of sodium salt and chloride
- Reduces plasma volume
- Increases plasma renin activity
- Increases aldosterone secretion
- Reduces potassium loss
Dosage & Administration
- Initiate with Telmisartan monotherapy 80 mg
- Telmisartan and Hydrochlorothiazide 80 mg/12.5 mg once daily
- Dose titration to 160 mg/25 mg after 2 to 4 weeks
- May be administered with other antihypertensive drugs
Interaction
- Caution with aliskiren, digoxin, lithium
- Caution with NSAIDs, corticosteroids, ACE blockers, angiotensin II receptor blockers
- May interfere with certain laboratory tests
Contraindications
- Hypersensitivity to Telmisartan or Hydrochlorothiazide
- Contraindicated with co-administered Aliskiren in patients with Diabetes
Side Effects
- Dizziness
- Drowsiness
- Flushing
- Back pain
- Nausea
- Diarrhea
- Stomach pain
- Elevations of liver enzymes
- Leg cramps
- Weakness
- Photosensitivity
- Urticaria
Pregnancy & Lactation
- Pregnancy Category D
- Reduces fetal renal function
- Increases fetal and neonatal morbidity and death
- Potential neonatal adverse effects
- Presence in human milk
- Thiazides in human milk
Precautions & Warnings
- Pre-existing medical conditions
- Effect on blood sugar
- Effect on body potassium levels
- Dizziness
- Dehydration prevention
Use in Special Populations
- Pediatric use not established
- Geriatric dose selection caution
- Close supervision for hepatic impairment initiations
- Not recommended in severe renal impairment
- No dose adjustment in mild or moderate renal impairment
Overdose Effects
- Hypertension
- Dizziness
- Tachycardia
- Bradycardia
- Hypokalemia
- Dehydration
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Keep in a cool and dry place
- Protect from light
Related Brands
- Telmilok Plus 40 mg+12.5 mg (Tablet) - square-pharmaceuticals-plc
- Telmitan Plus 80 mg+25 mg (Tablet) - opsonin-pharma-ltd
- Telmi-Z 80 mg+12.5 mg (Tablet) - doctor-tims-pharmaceuticals-ltd
- Telmipres Plus 80 mg+25 mg (Tablet) - incepta-pharmaceuticals-ltd
- Tems Plus 40 mg+12.5 mg (Tablet) - eskayef-pharmaceuticals-ltd